'Doctors mistook my liver disease for menopause'
On Tuesday, NICE - which recommends medicines for use on the NHS - recommended a daily pill for people with the disease, ...
News Medical16 天
Ipsen's elafibranor recommended for use in patients with rare liver disease
Ipsen announced today that the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg ...
Pharmaceutical Technology19 天
Intercept’s liver disease drug Ocaliva faces FDA approval delay
The original FDA full approval decision date was 15 October, but this has been delayed. Credit: Tada Images via Shutterstock. Intercept Pharmaceuticals will have to keep waiting for a decision about ...
The Pharma Letter20 天
NICE recommends Ipsen’s Iqirvo for PBC, a rare liver disease
Trade named Iqirvo, the drug is recommended in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA. This ...
Medscape10 年
The Role of Ursodeoxycholic Acid in Non-alcoholic Steatohepatitis
Effective therapy for NASH is still lacking. In this study, we investigated the effects of Ursodeoxycholic acid (UDCA) in the treatment of NASH. Methods: Western and Chinese databases were ...